Low Calorie Sweeteners Effects on Appetite

by palligoelme@gmail.com | Jun 13, 2025 | Clinical Trials

​ Conditions: Appetite Interventions: Dietary Supplement: rebaudioside A; Dietary Supplement: Placebo Sponsors: University of Manchester Completed Conditions: Appetite Interventions: Dietary Supplement: rebaudioside A; Dietary Supplement: Placebo Sponsors: University...

Effects of Integrated Neuromuscular Training on Physical Fitness in Badminton Athletes With Different Maturity Statuses

by palligoelme@gmail.com | Jun 13, 2025 | Clinical Trials

​ Conditions: Athletic Injuries Interventions: Other: integrated neuromuscular training Sponsors: National Taiwan Sport University Terminated Conditions: Athletic Injuries Interventions: Other: integrated neuromuscular training Sponsors: National Taiwan Sport...

QFR-Based Functional SYNTAX Score System in Optimizing Revascularization Strategy for Multivessel Disease

by palligoelme@gmail.com | Jun 13, 2025 | Clinical Trials

​ Conditions: Cardiovascular Diseases Interventions: Procedure: Traditional SYNTAX scoring; Procedure: QFR-Based Functional SYNTAX Score System Sponsors: First Affiliated Hospital of Harbin Medical University Not yet recruiting Conditions: Cardiovascular Diseases...

A Master Protocol of Multiple Interventions for the Treatment of Adults With Moderate-to-Severe Atopic Dermatitis.

by palligoelme@gmail.com | Jun 13, 2025 | Clinical Trials

​ Conditions: Atopic Dermatitis Interventions: Drug: LY3454738 Sponsors: Eli Lilly and Company Terminated Conditions: Atopic Dermatitis Interventions: Drug: LY3454738 Sponsors: Eli Lilly and Company Terminated 

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

by palligoelme@gmail.com | Jun 12, 2025 | Clinical Trials

​ Conditions: Episodic Migraine Interventions: Drug: Xeomin; Drug: Placebo Sponsors: Merz Therapeutics GmbH Not yet recruiting Conditions: Episodic Migraine Interventions: Drug: Xeomin; Drug: Placebo Sponsors: Merz Therapeutics GmbH Not yet...

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

by palligoelme@gmail.com | Jun 12, 2025 | Clinical Trials

​ Conditions: Kidney Disease, Chronic; Diabetes; Dialysis; End Stage Kidney Disease (ESRD) Interventions: Drug: Semaglutide Pen Sponsors: Unity Health Toronto Not yet recruiting Conditions: Kidney Disease, Chronic; Diabetes; Dialysis; End Stage Kidney Disease (ESRD)...